Mitchell Dowsett
Overview
Explore the profile of Mitchell Dowsett including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
6341
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wolff A, Somerfield M, Dowsett M, Hammond M, Hayes D, McShane L, et al.
Arch Pathol Lab Med
. 2023 Jun;
147(9):993-1000.
PMID: 37303228
Purpose.—: To update the American Society of Clinical Oncology-College of American Pathologists (ASCO-CAP) recommendations for human epidermal growth factor receptor 2 (HER2) testing in breast cancer. An Update Panel is...
2.
Wolff A, Somerfield M, Dowsett M, Hammond M, Hayes D, McShane L, et al.
J Clin Oncol
. 2023 Jun;
41(22):3867-3872.
PMID: 37284804
Purpose: To update ASCO-College of American Pathologists (CAP) recommendations for human epidermal growth factor receptor 2 (HER2) testing in breast cancer. The Panel is aware that a new generation of...
3.
Allison K, Hammond M, Dowsett M, McKernin S, Carey L, Fitzgibbons P, et al.
J Clin Oncol
. 2020 Jan;
38(12):1346-1366.
PMID: 31928404
Purpose: To update key recommendations of the American Society of Clinical Oncology/College of American Pathologists estrogen (ER) and progesterone receptor (PgR) testing in breast cancer guideline. Methods: A multidisciplinary international...
4.
Allison K, Hammond M, Dowsett M, McKernin S, Carey L, Fitzgibbons P, et al.
Arch Pathol Lab Med
. 2020 Jan;
144(5):545-563.
PMID: 31928354
Purpose.—: To update key recommendations of the American Society of Clinical Oncology/College of American Pathologists estrogen receptor (ER) and progesterone receptor (PgR) testing in breast cancer guideline. Methods.—: A multidisciplinary...
5.
Wolff A, Hammond M, Allison K, Harvey B, McShane L, Dowsett M
Arch Pathol Lab Med
. 2019 Jan;
143(4):413-414.
PMID: 30605367
No abstract available.
6.
Wolff A, Hammond M, Allison K, Harvey B, McShane L, Dowsett M
J Clin Oncol
. 2018 Oct;
:JCO1801163.
PMID: 30346904
No abstract available.
7.
Xiao T, Li W, Wang X, Xu H, Yang J, Wu Q, et al.
Proc Natl Acad Sci U S A
. 2018 Jul;
115(31):7869-7878.
PMID: 29987050
Endocrine therapy resistance invariably develops in advanced estrogen receptor-positive (ER) breast cancer, but the underlying mechanisms are largely unknown. We have identified C-terminal SRC kinase (CSK) as a critical node...
8.
Wolff A, Hammond M, Allison K, Harvey B, McShane L, Dowsett M
J Oncol Pract
. 2018 Jun;
14(7):437-441.
PMID: 29920138
No abstract available.
9.
Wolff A, Hammond M, Allison K, Harvey B, Mangu P, Bartlett J, et al.
J Clin Oncol
. 2018 May;
36(20):2105-2122.
PMID: 29846122
Purpose To update key recommendations of the American Society of Clinical Oncology/College of American Pathologists human epidermal growth factor receptor 2 (HER2) testing in breast cancer guideline. Methods Based on...
10.
Wolff A, Hammond M, Allison K, Harvey B, Mangu P, Bartlett J, et al.
Arch Pathol Lab Med
. 2018 May;
142(11):1364-1382.
PMID: 29846104
Purpose.—: To update key recommendations of the American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) human epidermal growth factor receptor 2 (HER2) testing in breast cancer guideline. Methods.—:...